← Leaderboards
Michael Oscar Harhay
University Of Pennsylvania
$3,671,438
Attributed
$6,522,481
Total exposure
7
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.8M · FY2015–25$5M$3.8M$2.5M$1.3M$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,522,481 · 7
By mechanism
R01$4,346,082 · 3
U01$1,144,421 · 1
R00$747,000 · 1
K99$213,755 · 1
F31$71,223 · 1
Top collaborators
- Fan Li3 shared
- Nuala Jennings Meyer3 shared
- Katherine Rinaldi Courtright2 shared
- John Patrick Reilly1 shared
- Nadir Yehya1 shared
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Martin Kneyber$3,209,610
- Olga F. Jarrãn Montaner$5,243,329
- Sanford No Middle Name Levine$2,086,800
- Mary Beth Leonard$17,530,683
- Peter S Klein$17,059,335
Others in their field
Top investigators on “Survivors”
- Joseph Sparano · Montefiore Medical Center (Bronx, Ny)$129,558,452
- Laurence H Baker · University Of Michigan At Ann Arbor$81,806,264
- Peter C Adamson · National Childhood Cancer Foundation$64,737,902
- Gregory Armstrong · St. Jude Children'S Research Hospital$61,535,149
- Deborah W Bruner · American College Of Radiology$57,347,005
- Daniel F Hanley · Johns Hopkins University$46,668,549
Research focus
SurvivorsCognitiveInnovationMorbidity - Disease RateQuality Of LifeEpidemiologyDesignFutureMortalityNational Heart, Lung, And Blood InstituteMethodologyEnrollmentPrognosticReportingIntensive Care UnitsResearch PersonnelFundingCessation Of LifeCaringPatient-Focused OutcomesHeterogeneityCohortClinical DataCommunities
Grant awards (16)
Pediatric Acute Respiratory distress syndrome MAnagement (PARMA)$767,069
R01 · FY2025 · HD
Advancing the design, analysis, and interpretation of acute respiratory distress syndrome trials using modern statistical tools$726,564
R01 · FY2025 · HL · contact PI
Improving the delivery and equity of inpatient palliative care: a hybrid type I pragmatic cluster trial$664,696
R01 · FY2025 · AG
Phenotyping ARDS, Pneumonia, and Sepsis over time to elucidate shared and distinct trajectories ofillness and recovery$634,751
U01 · FY2025 · HL
Advancing the design, analysis, and interpretation of acute respiratory distress syndrome trials using modern statistical tools$717,154
R01 · FY2024 · HL · contact PI
Improving the delivery and equity of inpatient palliative care: a hybrid type I pragmatic cluster trial$690,884
R01 · FY2024 · AG
Phenotyping ARDS, Pneumonia, and Sepsis over time to elucidate shared and distinct trajectories ofillness and recovery$350,420
U01 · FY2024 · HL
Advancing the design, analysis, and interpretation of acute respiratory distress syndrome trials using modern statistical tools$779,715
R01 · FY2023 · HL · contact PI
Phenotyping ARDS, Pneumonia, and Sepsis over time to elucidate shared and distinct trajectories ofillness and recovery$159,250
U01 · FY2023 · HL
Improving the measurement and analysis of long-term, patient-centered outcomes following acute respiratory failure$249,000
R00 · FY2022 · HL · contact PI
Improving the measurement and analysis of long-term, patient-centered outcomes following acute respiratory failure$249,000
R00 · FY2021 · HL · contact PI
Improving the measurement and analysis of long-term, patient-centered outcomes following acute respiratory failure$249,000
R00 · FY2020 · HL · contact PI
Improving the measurement and analysis of long-term, patient-centered outcomes following acute respiratory failure$108,012
K99 · FY2019 · HL · contact PI
Improving the measurement and analysis of long-term, patient-centered outcomes following acute respiratory failure$105,743
K99 · FY2018 · HL · contact PI
Methods to improve the detection of treatment effects in ARDS clinical trials$28,103
F31 · FY2016 · HL · contact PI
Methods to improve the detection of treatment effects in ARDS clinical trials$43,120
F31 · FY2015 · HL · contact PI